People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT06055868
- Status
- Recruiting
Conditions
- HIV Infections
- Oral Squamous Cell Carcinoma
- Oropharyngeal Squamous Cell Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Group Meeting (Focus Group) — OTHERFocus Group Discussions (FDGs) will be recorded, transcribed, and coded.
- Questionnaires — OTHERGiven electronically or via phone by study team staff
Study Details
This is an exploratory qualitative study among People Living With HIV (PLWH) of diverse racial/ethnic and sexual and gender minority (SGM) identities to explore individual, interpersonal, and structural oral health equity factors that serve as barriers or facilitators of accessing oral health care, knowledge and perceptions of human papillomavirus (HPV) vaccination and Oral squamous cell carcinoma (OSCC) /Oropharyngeal squamous cell carcinoma (OPSCC), and to collect recommendations on how to increase access to oral health care and engage PLWH in OSCC/OPSCC prevention.
Key Dates
- Start date
- Feb 13, 2025
- Status verified
- Mar 2025
- Primary completion
- Nov 30, 2029
- Completion
- Nov 30, 2029
Study Design
- Enrollment
- 144 participants (estimated)
Arms
- Arm: Qualitative Focus GroupParticipants will be asked to a series of questions to help place them in a focus group with other individuals of shared identity and will also complete a short quantitative survey either emailed to the participant or the outreach worker/study coordinator will administer the survey by phone. Participants will then participate in one 1.5-2 hour, facilitated, focus group discussions (FGD).
Primary Outcome Measure
Identification of potential oral health equity factors [ Time Frame: Up to 3 days ]
Central Contacts
- William Juarez(415) 437-7439
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | Alexandra Hernandez Levenston, PhD, MPH (PRINCIPAL_INVESTIGATOR) Joel Palefsky, MD (SUB_INVESTIGATOR) |
Find similar trials in San Francisco, CA
By condition
By specialty
By research site
Related Studies
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor EraRecruiting · University of California, San Francisco · San Francisco, California
- Imaging Immune Activation in HIV by PET-MRPHASE2 · Recruiting · CellSight Technologies, Inc. · San Francisco, California
- CAR-T Cells for HIV InfectionPHASE1/PHASE2 · Recruiting · Steven Deeks · Sacramento, California
- Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV PreventionRecruiting · Public Health Foundation Enterprises, Inc. · San Francisco, California